Skip to main content

Month: January 2025

Kaldalón hf.: Announcement from the Nomination Committee

The Nomination Committee of Kaldalón serves an advisory role in the selection of the Company’s Board of Directors and nominates candidates for board positions. Further details on the role of the Nomination Committee and its rules of procedure are available on Kaldalón’s website. The Nomination Committee of Kaldalón invites proposals for board members or declarations of candidacy for the upcoming Annual General Meeting of the company, scheduled for April 3, 2025. The committee requests that such information will be sent to the committee’s email address, tilnefningarnefnd@kaldalon.is, by 4:00 PM on January 31, 2025. Candidacies must include information on the candidacy form, which can be found on Kaldalón’s website. The above deadline does not restrict candidates’ right to submit candidacies within the timeframe stipulated...

Continue reading

Form 8.3 – [LOUNGERS PLC – 08 01 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LOUNGERS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing

Sharing Insights at the ‘Italy on the Move’ Event and Engaging Investors at Biotech Showcase During JPM Healthcare Week in San Francisco MILAN and NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) — Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased to announce that it has strengthened its partnership with AGC Biologics, a global contract development and manufacturing organization (CDMO), by amending their Development and Master Services Agreement. This amendment introduces an exclusive GMP suite at the AGC Biologics Cell and Gene Center of Excellence in Milan, dedicated to the manufacturing of Genenta’s cell therapy product, ensuring compliance with cGMP standards. This strategic move enhances Genenta’s production capabilities, potentially improving efficiency and...

Continue reading

O2 Czech Republic Launches Allot Solution to Offer Consumer Cybersecurity Services

Hod Hasharon, Israel, Jan. 09, 2025 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT), a leading global provider of innovative network intelligence and converged network-native security solutions for communication service providers and enterprises, today announced that O2 Czech Republic, a subsidiary of the PPF Group, has launched Allot DNS Secure, enabling them to continue offering and enhance cybersecurity protection services to both their mobile and fixed broadband consumer customers. This service launch is the result of an agreement between Allot and O2 Czech Republic signed earlier this year, and of an umbrella agreement signed with O2 Czech Republic parent company PPF Group to supply cybersecurity solutions to the group’s telecom provider subsidiaries. Allot will benefit from a recurring monthly fee for cybersecurity...

Continue reading

Openreach chooses Nokia to build open-access fiber network to connect millions to faster broadband

Press ReleaseOpenreach chooses Nokia to build open-access fiber network to connect millions to faster broadbandNokia building open access platform to accelerate fiber broadband services for millions of UK homes and businesses. Nokia’s intent-based model enables Openreach to reduce operations support systems (OSS) complexity by 85%. Nokia’s domain controllers allow Openreach to fully automate and simplify network operations, driving scalability and operational efficiency throughout its network.9 January 2025Espoo, Finland – Nokia today announced it has been chosen by Openreach to build its One Network Platform, an open-access fiber network to serve millions of homes and businesses. Built using Nokia’s Altiplano and NSP network domain controllers, the network will help Openreach grow from 17 million connected premises today to 25 million...

Continue reading

Correction: Final terms for bonds to be listed 10th January 2025

To Nasdaq Copenhagen A/S                        9th January 2025                                        Announcement no. 3/2025 CORRECTION: ISIN DK0009416893 is a Realkreditobligation (RO) Final terms for bonds to be listed 10th January 2025 On 10th January 2025, Jyske Realkredit A/S will be listing new Covered Bonds (SDO). Final terms for the bonds are attached to this announcement. The full prospectus for the Bonds consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated June 28th, 2024. Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s home page jyskerealkredit.com Yours...

Continue reading

Share Buyback Transaction Details January 2 – January 8, 2025

PRESS RELEASE                                         Share Buyback Transaction Details January 2 – January 8, 2025 Alphen aan den Rijn – January 9, 2025 – Wolters Kluwer (Euronext: WKL), a global leader in professional information, software solutions, and services, today reports that it has repurchased 82,234 of its own ordinary shares in the period from January 2, 2025, up to and including January 8, 2025, for €13.2 million and at an average share price of €160.00. These repurchases are part of the share buyback program announced on October 30, 2024, under which we intend to repurchase shares for €100 million during the period starting January 2, 2025, up to and including February 24, 2025. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2025Period Cumulative shares repurchased...

Continue reading

Photocat A/S and Essity Announce Partnership to Bring Sustainable Dust-Suppression Solution, InnoLig+©, to Key European Markets

January 9, 2025        Photocat A/S and Essity Announce Partnership to Bring Sustainable Dust-Suppression Solution, InnoLig+©, to Key European Markets Roskilde, Denmark. January 9, 2025 – Photocat A/S, a leading innovator in sustainable photocatalytic solutions as well as de-icing and dust-suppression products, is proud to announce a distribution and commercial partnership with Essity, a global leading hygiene and health company. This collaboration focuses on introducing InnoLig+©, a sustainable lignin-based dust-suppression solution, to key European markets, including the Nordics, Germany, United Kingdom, Poland, Baltics, Switzerland, and Spain. The partnership aims to meet the growing demand for effective and environmentally friendly dust-suppression technologies across Europe. The Serious Impact of Dust on Human Health: Dust pollution...

Continue reading

Philips appoints Jie Xue as Chief Business Leader Precision Diagnosis, co-leader of the Diagnosis & Treatment segment, and Özlem Fidanci as Chief of International Region

Jie XueÖzlem FidanciJanuary 9, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Jie Xue as Chief Business Leader Precision Diagnosis, and Özlem Fidanci as Chief of International Region, both effective January 1, 2025. Ms. Xue and Ms. Fidanci have joined Philips’ Executive Committee and report directly to Roy Jakobs, CEO of Philips. Ms. Xue joins Philips from GE Healthcare to lead the Precision Diagnosis business that was temporarily led by Bert van Meurs, who will continue to lead Philips’ Image Guided Therapy business. Ms. Xue and Mr. Van Meurs will be jointly responsible for the Diagnosis & Treatment segment. Ms. Fidanci joins from Versuni and succeeds Edwin Paalvast, Chief of International Region, who has decided...

Continue reading

Ultimovacs ASA – Extraordinary General Meeting held on January 9, 2025

Oslo, January 9, 2025: Ultimovacs ASA held its extraordinary general meeting today January 9, 2025. All the matters on the agenda were approved. The minutes from the meeting are enclosed and available at the company’s website. For further information, please see www.ultimovacs.com or contact: Jónas Einarsson, Chair of the Board of Directors of Ultimovacs ASA Email: je@radforsk.no Phone: +47 480 96 355 Hans Vassgård Eid, CFO and Interim CEO, Ultimovacs ASA Email: hans.eid@ultimovacs.com Phone: +47 482 48632AttachmentMinutes of the Extraordinary General Meeting 2025 in Ultimovacs ASA

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.